Markets Earnings Screener Watchlist

Fundamentals and filings are sourced from SEC EDGAR. Market data, ownership and analyst consensus are sourced from Nasdaq. Written analysis is generated by metir from those sources and the linked reporting.

All information is provided for informational purposes only. It is not investment, financial, tax or legal advice, is not a recommendation to buy or sell any security, and is not intended for trading purposes. Data may be delayed or incomplete.

Regeneron Pharmaceuticals, Inc. Stock Price: Quote, Financials, Forecast & News (REGN)

Markets open

Regeneron Pharmaceuticals, Inc.

REGN · Nasdaq

Overview Financials Earnings Holders Historical Data Analysis

Symbol: REGN
Type: Stock
Sector: Health Care
Industry: Biotechnology: Pharmaceutical Preparations
Country: North America
Exchange: Nasdaq

Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite ®, which produces optimized fully human antibodies and new classes of bispecific antibodies.

Analyst Consensus

Buy

21 analysts

$775

Current

—

Low

$857

Average

—

High

Average target implies +10.54% versus the current price.

Earnings History

BeatMissNo estimate

Peers

GSK plc American Depositary Shares (Each representing two Ordinary Shares)GSK · NYSE$51.48

0.10%

Sanofi ADSSNY · Nasdaq$43.121.03%

Medtronic plc. Ordinary SharesMDT · NYSE$85.560.74%

Vertex Pharmaceuticals IncorporatedVRTX · NASDAQ-GS$482.570.81%

$775.29+$14.631.92%

As of: Aug 5, 2:33 PM

Prev Close: $760.66
Market Cap: $79.82B
Open: —
Trailing P/E: —
Day Range: $782.59 - $767.98
52W Range: $821.11 - $541.00
Forward P/E: —
EPS: —
Volume: 96.12K
Dividend Yield: 0.49%

Notable Price Movement

Weekly movement commentary will appear here once it has been generated for this company.

Stories & Analysis

BAYRY Beats on Q2 Earnings, Crop Science Business Boosts Growth

Zacks · 1d ago

Regeneron (REGN) is a Top-Ranked Value Stock: Should You Buy?

Zacks · 1d ago

Amgen Q2 Earnings Preview: Will the Beat Streak Continue?

Zacks · 5d ago

ALNY Stock Tanks 28% as Q2 Earnings Miss Estimates, '26 Sales View Cut

Zacks · 5d ago

Company News for July 31, 2026

Zacks · 5d ago Biotech Stocks Facing FDA Decision In August 2026

RTTNews · 5d ago Regeneron (REGN) Q2 2026 Earnings Call Transcript

The Motley Fool · 6d ago Regeneron Pharmaceuticals Q2 Earnings Call Highlights

MarketBeat · 6d ago

Beta

—

Avg Volume

983.32K